Key result
Hydrogel-delivered rhSGK3 improves cardiac function and promotes repair after ischemia/reperfusion injury in mice.
Why the study?
Current therapies for myocardial infarction fail to promote cardiac regeneration, and novel strategies to enhance myocardial repair are needed.
Does intramyocardial injection of rhSGK3-hydrogel improve cardiac repair in a mouse model of ischemia/reperfusion injury?
Does intramyocardial injection of rhSGK3-hydrogel improve cardiac repair in a mouse model of ischemia/reperfusion injury?
Local delivery of rhSGK3 via a thermosensitive hydrogel promotes cardiac repair after ischemia/reperfusion injury through HIF-1α/HK2-mediated glycolytic reprogramming.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for rhSGK3-hydrogel in post-infarct repair; leaves open translation to human ischemia/reperfusion injury.
Myocardial infarction (MI) leads to substantial cardiomyocyte loss and heart failure, whereas current therapies fail to promote cardiac regeneration. Our prior work demonstrated that serum and glucocorticoid-regulated kinase 3 (SGK3) promote cardiac repair. To overcome the limitations of viral gene therapy, we develop a recombinant human SGK3 (rhSGK3) protein fused with a cell-penetrating peptide and encapsulate it in a thermosensitive PLGAPEG-PLGA hydrogel for sustained local delivery. In vitro, rhSGK3 efficiently enters neonatal mouse cardiomyocytes and significantly promotes proliferation, reduces OGD/R-induced apoptosis, stabilizes OGD/R-induced mitochondrial membrane potential, and upregulates the expressions of glycolytic enzymes including PKM2, LDHA, PFKP, and HK2, while shifting energy metabolism from oxidative phosphorylation toward glycolysis. These effects are reversed by the glycolysis inhibitor 2-DG. Mechanistically, rhSGK3 activates the HIF-1α/HK2 signaling axis, and HIF-1αknockdown abolishes its pro-proliferative and anti-apoptotic effects. In an in vivo myocardial ischemia/reperfusion (I/R) mouse model, intramyocardial injection of rhSGK3-hydrogel preserves mitochondrial ultrastructure, enhances cardiomyocyte proliferation, reduces apoptosis, attenuates fibrotic scar formation, and significantly improves cardiac function at 28 days post-I/R. Importantly, HIF-1α knockdown in vivo reverses these protective effects. Together, these findings suggest that local delivery of rhSGK3 via a thermosensitive hydrogel promotes cardiac repair after I/R injury through HIF-1α/HK2-mediated glycolytic reprogramming and mitochondrial protection. This study presents a promising protein-based, gene-integration-free therapeutic strategy for myocardial repair.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2026) studied Myocardial ischemia/reperfusion injury. Recombinant human SGK3 (rhSGK3) protein hydrogel was evaluated on Cardiac function, cardiomyocyte proliferation, apoptosis, and fibrotic scar formation. Local delivery of rhSGK3 via a thermosensitive hydrogel significantly improved cardiac function and promoted cardiac repair after ischemia/reperfusion injury in a mouse model.
Synapse has enriched 10 related papers. Consider them for comparative context: